Download Free Sample Report

Global End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2028

Global End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2028

  • Published on : 22 July 2022
  • Pages :88
  • Report Code:SMR-7226948

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

End-Stage Renal Disease (ESRD) Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global End-Stage Renal Disease (ESRD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Calcium Succinate
  • Mk-3866
  • Pacritinib
  • Sanguinate
  • Tesidolumab
  • Others

Segment by Application

  • Hospital
  • Clinic
  • ICU
  • Others

By Company

  • CTI BioPharma Corp
  • Merck & Co Inc
  • Novartis AG
  • Prolong Pharmaceuticals LLC
  • VESSL Therapeutics Ltd

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE